131 related articles for article (PubMed ID: 24650220)
1. Five cases of interstitial lung disease after leflunomide was combined with methotrexate therapy.
Rutanen J; Kononoff A; Arstila L; Elfving P; Koskela H; Kaipiainen-Seppänen O
Scand J Rheumatol; 2014; 43(3):254-6. PubMed ID: 24650220
[No Abstract] [Full Text] [Related]
2. Leflunomide use and the risk of interstitial lung disease in rheumatoid arthritis.
Suissa S; Hudson M; Ernst P
Arthritis Rheum; 2006 May; 54(5):1435-9. PubMed ID: 16645972
[TBL] [Abstract][Full Text] [Related]
3. Risk of interstitial lung disease associated with leflunomide treatment in Korean patients with rheumatoid arthritis.
Ju JH; Kim SI; Lee JH; Lee SI; Yoo WH; Choe JY; Chung SH; Lee J; Lee YH; Lee SS; Yoon HJ; Yoon CH; Kim HY; Park SH
Arthritis Rheum; 2007 Jun; 56(6):2094-6. PubMed ID: 17530652
[No Abstract] [Full Text] [Related]
4. Methotrexate versus leflunomide in rheumatoid arthritis: what is new in 2011?
Singer O; Gibofsky A
Curr Opin Rheumatol; 2011 May; 23(3):288-92. PubMed ID: 21378570
[TBL] [Abstract][Full Text] [Related]
5. Benefit-risk assessment of leflunomide: an appraisal of leflunomide in rheumatoid arthritis 10 years after licensing.
Alcorn N; Saunders S; Madhok R
Drug Saf; 2009; 32(12):1123-34. PubMed ID: 19916579
[TBL] [Abstract][Full Text] [Related]
6. The SMILE study -- safety of methotrexate in combination with leflunomide in rheumatoid arthritis.
Bird P; Griffiths H; Tymms K; Nicholls D; Roberts L; Arnold M; Burnet S; de Jager J; Scott J; Zochling J; Littlejohn G
J Rheumatol; 2013 Mar; 40(3):228-35. PubMed ID: 23322457
[TBL] [Abstract][Full Text] [Related]
7. Leflunomide induced acute interstitial pneumonia.
Takeishi M; Akiyama Y; Akiba H; Adachi D; Hirano M; Mimura T
J Rheumatol; 2005 Jun; 32(6):1160-3. PubMed ID: 15940779
[TBL] [Abstract][Full Text] [Related]
8. Comparative effectiveness of tumour necrosis factor alpha inhibitors in combination with either methotrexate or leflunomide.
Strangfeld A; Hierse F; Kekow J; von Hinueber U; Tony HP; Dockhorn R; Listing J; Zink A
Ann Rheum Dis; 2009 Dec; 68(12):1856-62. PubMed ID: 19126559
[TBL] [Abstract][Full Text] [Related]
9. Combination treatment with leflunomide and methotrexate for patients with active rheumatoid arthritis.
Lee SS; Park YW; Park JJ; Kang YM; Nam EJ; Kim SI; Lee JH; Yoo WH; Lee SI
Scand J Rheumatol; 2009; 38(1):11-4. PubMed ID: 19191187
[TBL] [Abstract][Full Text] [Related]
10. Leflunomide, a new disease-modifying drug for treating active rheumatoid arthritis in methotrexate-controlled phase II clinical trial.
Bao C; Chen S; Gu Y; Lao Z; Ni L; Yu Q; Xu J; Li X; Liu J; Sun L; He P; Ma J; Xu S; Ding C
Chin Med J (Engl); 2003 Aug; 116(8):1228-34. PubMed ID: 12935395
[TBL] [Abstract][Full Text] [Related]
11. Leflunomide-induced acute interstitial pneumonia in a patient treated for rheumatoid arthritis.
Maskey-Warzęchowska M; Karwat K; Szczepankiewicz B; Langfort R; Szołkowska M; Chazan R
Pneumonol Alergol Pol; 2015; 83(1):50-4. PubMed ID: 25577534
[TBL] [Abstract][Full Text] [Related]
12. Leflunomide-associated pancytopenia with or without methotrexate.
Chan J; Sanders DC; Du L; Pillans PI
Ann Pharmacother; 2004; 38(7-8):1206-11. PubMed ID: 15187208
[TBL] [Abstract][Full Text] [Related]
13. Comparative effectiveness of rituximab in combination with either methotrexate or leflunomide in the treatment of rheumatoid arthritis.
Narváez J; Díaz-Torné C; Ruiz JM; Hernández MV; Torrente-Segarra V; Ros S; Rodriguez de la Serna A; Díaz-López C; Sanmartí R; Nolla JM
Semin Arthritis Rheum; 2011 Dec; 41(3):401-5. PubMed ID: 21862107
[TBL] [Abstract][Full Text] [Related]
14. Interstitial lung diseases after leflunomide use in nephropathy: an analysis of reported cases in Chinese literature.
Zhang WX; Zhou W; Zhang ZQ; Zhao XW
Nephrol Dial Transplant; 2011 Apr; 26(4):1416-20. PubMed ID: 21193642
[TBL] [Abstract][Full Text] [Related]
15. Rheumatoid arthritis complicated with acute interstitial pneumonia induced by leflunomide as an adverse reaction.
Kamata Y; Nara H; Kamimura T; Haneda K; Iwamoto M; Masuyama J; Okazaki H; Minota S
Intern Med; 2004 Dec; 43(12):1201-4. PubMed ID: 15645660
[TBL] [Abstract][Full Text] [Related]
16. Is there a place for leflunomide in the treatment of rheumatoid arthritis?
Breedveld FC
Lancet; 2001 Oct; 358(9289):1198-200. PubMed ID: 11675052
[No Abstract] [Full Text] [Related]
17. Does methotrexate cause interstitial lung disease in rheumatoid arthritis: What is the evidence?
Malaviya AN
Int J Rheum Dis; 2020 Jun; 23(6):713-716. PubMed ID: 32573124
[No Abstract] [Full Text] [Related]
18. Update 2011: leflunomide in rheumatoid arthritis - strengths and weaknesses.
Behrens F; Koehm M; Burkhardt H
Curr Opin Rheumatol; 2011 May; 23(3):282-7. PubMed ID: 21427581
[TBL] [Abstract][Full Text] [Related]
19. [Drug therapy and malpractice exemplified by combination leflunomide and methotrexate therapy].
Burgardt C
Z Rheumatol; 2002 Apr; 61(2):189-90. PubMed ID: 12056298
[No Abstract] [Full Text] [Related]
20. [Adverse effects of DMARDs in treatment of rheumatoid arthritis].
Sugii S
Nihon Rinsho; 2005 Jan; 63 Suppl 1():566-72. PubMed ID: 15799419
[No Abstract] [Full Text] [Related]
[Next] [New Search]
